ArticleQatar medical journal2026
Moyamoya disease masquerading as CNS vasculitis: Diagnostic challenges and imaging insights.
Article in Qatar medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder that can mimic central nervous system (CNS) vasculitis on imaging, particularly when advanced imaging techniques, such as vessel wall imaging, are used; thereby creating significant diagnostic uncertainty. Case Presentation: A 38-year-old woman presented with a one-week history of headache and binocular diplopia. Neuroimaging demonstrated a subacute right occipitoparietal infarct. Magnetic resonance angiography showed multifocal stenoses with extensive collateral vessels. High-resolution vessel wall imaging demonstrated circumferential enhancement, initially raising concern for CNS vasculitis; however, cerebrospinal fluid analysis was non-inflammatory, and autoimmune and infectious panels were negative. Digital subtraction angiography confirmed bilateral terminal internal carotid artery stenosis with lenticulostriate collaterals, consistent with MMD. The presence of a positive family history of MMD further supported the diagnosis. She improved clinically, was discharged on aspirin, and remained asymptomatic at neurosurgery follow-up. Discussion: This case highlights the diagnostic challenges in differentiating MMD from CNS vasculitis. The presence of circumferential vessel wall enhancement, which is not specific and may overlap with inflammatory vasculopathies, illustrates how reliance on vessel wall imaging alone can be misleading. This case emphasizes the importance of integrating clinical, laboratory, radiological, and familial data to distinguish non-inflammatory arteriopathies from true vasculitis accurately. Similar diagnostic dilemmas have been reported in the literature, emphasizing the need for careful evaluation to avoid unnecessary immunosuppressive treatment. Conclusion: Differentiating MMD from CNS vasculitis requires careful integration of clinical, radiological, and familial data to prevent misdiagnosis and unnecessary immunosuppression. A structured, multimodal diagnostic approach is essential, particularly when imaging findings are atypical or potentially misleading. Early recognition and appropriate management can lead to favorable outcomes, as illustrated by our patient, who showed complete recovery and remained symptom-free on medical therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.